Literature DB >> 2053286

Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation.

F Lafay1, P Coulon, L Astic, D Saucier, D Riche, A Holley, A Flamand.   

Abstract

After intranasal instillation in the mouse, rabies virus (CVS strain) selectively infected olfactory receptor cells. In the main olfactory bulb (MOB), infection was observed in periglomerular, tufted, and mitral cells and in interneurons located in the internal plexiform layer. Beyond the MOB, CVS spread into the brain along the olfactory pathways. This infection is specific to chains of functionally related neurons but at the death of the animal some nuclei remain uninfected. CVS also penetrated the trigeminal system. The avirulent mutant AvO1, carrying a mutation in position 333 of the glycoprotein, infected the olfactory epithelium and the trigeminal nerve as efficiently as CVS. During the second cycle of infection, the mutant was able to infect efficiently periglomerular cells in the MOB and neurons of the horizontal limb of the diagonal band, which indicates that maturation of infective particles is not affected in primarily infected neuronal cells. On the other hand, other neuronal cells permissive for CVS, such as mitral cells or the anterior olfactory nucleus, are completely free of infection with the mutant, indicating that restriction is related to the ability of AvO1 to penetrate several categories of neurons. From these observations, we concluded that CVS should be able to bind several different receptors to penetrate neurons, while the mutant would be unable to recognize some of them.

Entities:  

Mesh:

Year:  1991        PMID: 2053286      PMCID: PMC7131780          DOI: 10.1016/0042-6822(91)90145-2

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  31 in total

1.  Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein.

Authors:  I Seif; P Coulon; P E Rollin; A Flamand
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

2.  Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro.

Authors:  B Dietzschold; T J Wiktor; J Q Trojanowski; R I Macfarlan; W H Wunner; M J Torres-Anjel; H Koprowski
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

3.  Amino acid sequence similarity between rabies virus glycoprotein and snake venom curaremimetic neurotoxins.

Authors:  T L Lentz; P T Wilson; E Hawrot; D W Speicher
Journal:  Science       Date:  1984-11-16       Impact factor: 47.728

4.  Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence.

Authors:  P Coulon; P E Rollin; A Flamand
Journal:  J Gen Virol       Date:  1983-03       Impact factor: 3.891

5.  Avirulent mutants of the CVS strain of rabies virus.

Authors:  P Coulon; P Rollin; J Blancou; A Flamand
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1982       Impact factor: 2.268

6.  Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice.

Authors:  C Tuffereau; H Leblois; J Bénéjean; P Coulon; F Lafay; A Flamand
Journal:  Virology       Date:  1989-09       Impact factor: 3.616

7.  Non-lethal infection of aminergic reticular core neurons: age-dependent spread of ts mutant vesicular stomatitis virus from the nose.

Authors:  B Lundh; A Löve; K Kristensson; E Norrby
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

8.  Early street rabies virus infection in striated muscle and later progression to the central nervous system.

Authors:  F A Murphy; S P Bauer
Journal:  Intervirology       Date:  1974       Impact factor: 1.763

9.  Is the acetylcholine receptor a rabies virus receptor?

Authors:  T L Lentz; T G Burrage; A L Smith; J Crick; G H Tignor
Journal:  Science       Date:  1982-01-08       Impact factor: 47.728

10.  Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.

Authors:  B Dietzschold; W H Wunner; T J Wiktor; A D Lopes; M Lafon; C L Smith; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1983-01       Impact factor: 11.205

View more
  45 in total

Review 1.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

Review 2.  Olfactory transmission of neurotropic viruses.

Authors:  Isamu Mori; Yukihiro Nishiyama; Takashi Yokochi; Yoshinobu Kimura
Journal:  J Neurovirol       Date:  2005-04       Impact factor: 2.643

3.  Monosynaptic restriction of transsynaptic tracing from single, genetically targeted neurons.

Authors:  Ian R Wickersham; David C Lyon; Richard J O Barnard; Takuma Mori; Stefan Finke; Karl-Klaus Conzelmann; John A T Young; Edward M Callaway
Journal:  Neuron       Date:  2007-03-01       Impact factor: 17.173

4.  Reversible conformational changes and fusion activity of rabies virus glycoprotein.

Authors:  Y Gaudin; C Tuffereau; D Segretain; M Knossow; A Flamand
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Folding of rabies virus glycoprotein: epitope acquisition and interaction with endoplasmic reticulum chaperones.

Authors:  Y Gaudin
Journal:  J Virol       Date:  1997-05       Impact factor: 5.103

Review 6.  The Olfactory Bulb: An Immunosensory Effector Organ during Neurotropic Viral Infections.

Authors:  Douglas M Durrant; Soumitra Ghosh; Robyn S Klein
Journal:  ACS Chem Neurosci       Date:  2016-04-08       Impact factor: 4.418

7.  Characterization of protein involvement in rabies virus binding to BHK-21 cells.

Authors:  J H Broughan; W H Wunner
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

8.  An avirulent mutant of rabies virus is unable to infect motoneurons in vivo and in vitro.

Authors:  P Coulon; J P Ternaux; A Flamand; C Tuffereau
Journal:  J Virol       Date:  1998-01       Impact factor: 5.103

9.  Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity.

Authors:  H Badrane; C Bahloul; P Perrin; N Tordo
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

10.  Rabies virus is not cytolytic for rat spinal motoneurons in vitro.

Authors:  Céline Guigoni; Patrice Coulon
Journal:  J Neurovirol       Date:  2002-08       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.